Chaparro M., Acosta D., Rodríguez C., Mesonero F., Vicuña M., Barreiro-De Acosta M., Fernández-Clotet A., Hernández Martínez Á., Arroyo M., Vera I., Ruiz-Cerulla A., Sicilia B., Cabello Tapia M.J., Muñoz Villafranca C., Castro-Poceiro J., Martínez Cadilla J., Sierra-Ausín M., Vázquez Morón J.M., Vicente Lidón R., Bermejo F., Royo V., Calafat M., González-Muñoza C., Leo Carnerero E., Manceñido Marcos N., Torrealba L., Alonso-Galán H., Benítez J.M., Ber Nieto Y., Diz-Lois Palomares M.T., García M.J., Muñoz J.F., Armesto González E.M., Calvet X., Hernández-Camba A., Madrigal Domínguez R.E., Menchén L., Pérez Calle J.L., Piqueras M., Dueñas Sadornil C., Botella B., Martínez-Pérez T.D.J., Ramos L., Rodríguez-Grau M.C., San Miguel E., Fernández Forcelledo J.L., Fradejas Salazar P.M., García-Sepulcre M., Gutiérrez A., Llaó J., Sesé Abizanda E., Boscá-Watts M., Iyo E., Keco-Huerga A., Martínez Bonil C., Peña González E., Pérez-Galindo P., Varela P., Gisbert J.P.. Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2023; 118(7)DOI:10.14309/ajg.0000000000002145. PMID:36716287. IF:8.500(Q1/1D).

Villanueva C., Tripathi D.. Carvedilol, probably the ß-blocker of choice for everyone with cirrhosis and portal hypertension: But not so fast!. LIVER INTERNATIONAL. 2023; 43(6)DOI:10.1111/liv.15582. PMID:37166136. IF:6.000(Q1/2D).

Torrico M.C., Fernández-Arévalo A., Ballart C., Solano M., Rojas E., Abras A., Gonzales F., Arnau A., Tebar S., Llovet T., Lozano D., Ariza-Vioque E., Gascón J., Picado A., Torrico F., Munoz, C, Gállego M.. Usefulness of Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry in the Characterization of Leishmania Strains Causing Tegumentary Leishmaniasis in Bolivia versus hsp70 Gene Sequencing. Microbiology Spectrum. 2023; 11(1)DOI:10.1128/spectrum.03477-22. PMID:36633426. IF:3.700(Q2/4D).

Becerra-Aparicio F., Gómez-Zorrilla S., Hernández-García M., Gijón D., Siverio A., Berbel D., Sánchez-Carrillo C., Cercenado E., Rivera A., de Malet A., Xercavins M., Ruiz de Gopegui E., Canoura-Fernández L., Martínez J.A., Seral C., Del Pozo J.L., Cotarelo M., Díaz-Regañón J., Cantón R., Oliver A., Horcajada J.P., Ruiz-Garbajosa P.. Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project). JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2023; 78(9)DOI:10.1093/jac/dkad234. PMID:37533351. IF:3.900(Q1/3D).